drugset / Trial / NCT03095222

Exploring the Safety and Efficacy of Low-dose Ketamine Infusions for Pain Control in Acute Burn Injury

NCT03095222 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to identify the optimal dosing strategy for low-dose ketamine infusions in adult acute burn injury patients when used with usual pain medications.

Timeline

Start
2017-04-01
Primary completion
2018-05-24
Completion
2018-05-24

Outcome

Outcome not reported

Stopped (Enrollment): “The study never screened or enrolled any subjects due to stalled recruitment efforts.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 20 mg Intravenous

Indications

No indication recorded.